First Header Logo Second Header Logo

Evaluation of a novel point-of-care enoxaparin monitor with central laboratory anti-Xa levels.

Saw J, Kereiakes DJ, Mahaffey KW, Applegate RJ, Braden GA, Brent BN, Brodie BR, Groce JB, Levine GN, Leya F, Moliterno DJ. Evaluation of a novel point-of-care enoxaparin monitor with central laboratory anti-Xa levels. Thromb Res. 2003; 112(5-6):301-6.

View in: PubMed